Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment

Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment

Objective: The metabolic influence of gut microbiota plays a pivotal role in the pathogenesis of cardiometabolic diseases. Antibiotics affect intestinal bacterial diversity, and long-term usage has been identified as an independent risk factor for atherosclerosis-driven events. The aim of this study...

Full description

Bibliographic Details
Main Authors: Ben Arpad Kappel, Lorenzo De Angelis, Michael Heiser, Marta Ballanti, Robert Stoehr, Claudia Goettsch, Maria Mavilio, Anna Artati, Omero A. Paoluzi, Jerzy Adamski, Geltrude Mingrone, Bart Staels, Remy Burcelin, Giovanni Monteleone, Rossella Menghini, Nikolaus Marx, Massimo Federici
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Molecular Metabolism
Subjects:
Atherosclerosis
Antibiotics
Gut microbiota
Dysbiosis
Metabolic diversity
Cross-omics
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877820300491

Internet

http://www.sciencedirect.com/science/article/pii/S2212877820300491

Similar Items